The present invention relates to mutated genes encoding variants of an Erwinia-type
creatinase (EC 3.5.3.3, alternative name: creatine amidinohydrolase), to the creatinase
variants encoded by these genes, and to different applications of these variants
of creatinase, particularly to their use for determining the creatinine and/or
creatine concentration in a sample.